Fibroblast growth factor 1 alleviates diabetic nephropathy by reducing renal lipid accumulation in diabetic kidney
FGF1 alleviates DN by inhibiting fatty acid uptake and promoting lipid catabolism <i>via</i> AMPK activation and FAO enhancement.
Authors
- Yingjian Li (ORCID: https://orcid.org/0000-0002-0653-4535)
- Yujia Xi (ORCID: https://orcid.org/0000-0002-2590-2428)
- Fan Xia (ORCID: https://orcid.org/0000-0002-2551-0774)
- Xiaoqing Yan (ORCID: https://orcid.org/0000-0001-9113-5274)
- Chi Zhang
- Hao-Yu Chen
- He-Yu Ge
- Gui-Gui Zhang
- Yin-Li Huang
- Kai Wang
Institutions
- Wenzhou Medical University (CN)
- Shanghai Children's Medical Center (CN)
- Ruian People's Hospital (CN)
Publication Details
- Journal
- World Journal of Diabetes
- Published
- 2026-02-06
- DOI
- https://doi.org/10.4239/wjd.v17.i2.112475
- Primary Topic
- Fibroblast Growth Factor Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00